Treatments for IBS

FromThe Lancet Gastroenterology & Hepatology in conversation with

Start listening View podcast show

Treatments for IBS

FromThe Lancet Gastroenterology & Hepatology in conversation with

ratings:

Length:

8 minutes

Released:

Jan 14, 2020

Format:

Podcast episode

Description

Professor Alexander Ford discusses a meta analysis comparing different traditional treatments for irritable bowel syndrome.

Released:

Jan 14, 2020

Format:

Podcast episode

Titles in the series (75)

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

Raymond Henderson on the economic burden of colorectal cancer by The Lancet Gastroenterology & Hepatology in conversation with
11 min listen
Barrett's oesophagus: The Lancet Gastroenterology & Hepatology: Jan 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Reducing population alcohol consumption: The Lancet Gastroenterology & Hepatology: August 10, 2016 by The Lancet Gastroenterology & Hepatology in conversation with
19 min listen
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Migraine and GI disorders: The Lancet Gastroenterology & Hepatology: September 7, 2016 by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017 by The Lancet Gastroenterology & Hepatology in conversation with
11 min listen
Treatment of an appendix mass in children: The Lancet Gastroenterology & Hepatology: March 8, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Inflammatory bowel disease: The Lancet Gastroenterology & Hepatology: December issue by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
UDCA Response Score by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
13 min listen
Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
22 min listen
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018 by The Lancet Gastroenterology & Hepatology in conversation with
19 min listen
Can DAA therapy for HCV reactivate HBV in coinfected patients? by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018 by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Global prevalence, treatment, and prevention of hepatitis B virus infection by The Lancet Gastroenterology & Hepatology in conversation with
13 min listen
Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Neoplasia detection in ulcerative colitis by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
DAA treatment for hepatitis C among people who inject drugs by The Lancet Gastroenterology & Hepatology in conversation with
11 min listen
Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Epidemiology of chronic liver disease by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Treatments for IBS by The Lancet Gastroenterology & Hepatology in conversation with
8 min listen
Acute hepatitis C by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Pancreatic cancer treatment by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Liver damage in young adults by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Caroline Ovadia on intrahepatic cholestasis of pregnancy by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Treating faecal incontinence in women by The Lancet Gastroenterology & Hepatology in conversation with
8 min listen
Faecal microbiota transplantation in IBS by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen

More Episodes from The Lancet Gastroenterology & Hepatology in conversation with

Skip carousel

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS by The Lancet Gastroenterology & Hepatology in conversation with
23 min listen
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease by The Lancet Gastroenterology & Hepatology in conversation with
20 min listen
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa by The Lancet Gastroenterology & Hepatology in conversation with
21 min listen
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity by The Lancet Gastroenterology & Hepatology in conversation with
23 min listen
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Anna Kann on the causes of mortality in patients with alcohol-related liver disease by The Lancet Gastroenterology & Hepatology in conversation with
16 min listen
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease by The Lancet Gastroenterology & Hepatology in conversation with
18 min listen
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis by The Lancet Gastroenterology & Hepatology in conversation with
13 min listen
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Johan Burisch on the costs of inflammatory bowel disease in high-income settings by The Lancet Gastroenterology & Hepatology in conversation with
20 min listen
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease by The Lancet Gastroenterology & Hepatology in conversation with
22 min listen
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer by The Lancet Gastroenterology & Hepatology in conversation with
20 min listen
Dan Turner on vedolizumab in children with IBD by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
James Alexander immune responses to COVID-19 vaccination in patients with IBD by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Filip Knop on liraglutide for bile acid diarrhoea by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Juan Pablo Arab on NAFLD public health policies in the Americas by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Sarah Blach on hepatitis C virus epidemiology by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Swati Patel on early-onset colorectal cancer by The Lancet Gastroenterology & Hepatology in conversation with
19 min listen
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa by The Lancet Gastroenterology & Hepatology in conversation with
23 min listen

Discover this podcast and so much more

Treatments for IBS

Treatments for IBS

Description

Titles in the series (75)

More Episodes from The Lancet Gastroenterology & Hepatology in conversation with